Skip to content

Welcome to Discover Pharma! Today is : October 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

cancer diagnostics

  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    MRI study suggests some prostate cancer biopsies could eventually be avoided

    A study of 880 men found clinically significant prostate cancer [...]

    August 26, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Leicester clinic offers Galleri blood test following NHS cancer trial

    A Leicester private GP clinic has begun offering Galleri, a [...]

    August 24, 2026
  • Clinical & Regulatory,Digital & Data,Genomics and sequencing

    Quest Diagnostics expands access to molecular cancer testing through OncoEMR

    Quest Diagnostics has integrated its Haystack MRD test and comprehensive [...]

    July 9, 2026
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Vortex Biotech opens new laboratory at Manchester Science Park to expand liquid biopsy development

    Vortex Biotech Holdings has opened a new laboratory facility at [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    UK clears Mainz Biomed’s ColoAlert for colorectal cancer screening

    Mainz Biomed has received official registration from the UK Medicines [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Mainz Biomed targets US approval for next-gen CRC test and expands into pancreatic cancer

    Mainz Biomed says it is preparing to launch a pivotal [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    One Biosciences raises €15M to advance AI-driven single-cell oncology platform

    One Biosciences, a precision oncology techbio company specialising in clinical-grade [...]

    May 5, 2026
  • Therapeutic Areas

    Tagomics secures £860k Innovate UK grant to advance early detection of colorectal cancer

    Project aims to apply multiomic profiling for non-invasive diagnostic development [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Biostate AI raises $12M to build the ‘Netflix’ of molecular diagnostics using RNAseq and GenAI

    Biostate AI has raised $12 million in Series A funding [...]

    May 5, 2026
  • Drug Discovery & Development,Opinion & Events,Uncategorised

    SpotitEarly targets US market with AI-canine breath test for early cancer detection

    A biotech company combining artificial intelligence with canine scent detection [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Merck highlights RDKit’s role in AI-driven drug discovery
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Research & Development
  • Novadip secures €10.4M to advance pivotal Phase 3 trial
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Telix to acquire ITM in $1.65BN radiopharmaceutical deal
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top